Tianeptine, known as “gas station heroin,” is a drug that was once used to treat depression in many countries. In the United States, there has been a significant increase in cases involving tianeptine, a drug that poses risks of overdose and dependency. While it’s not FDA approved, it’s readily available in gas stations, stores, and online.
Despite not being approved for medical use in the U.S., tianeptine is sold as a nootropic promising to enhance mood and cognitive function. It’s crucial to avoid consuming unapproved drugs due to the risks they pose, such as dependency, withdrawal, and respiratory depression. These rogue tianeptine products, often packaged in colorful bottles, contain varying concentrations of the drug and may also include dangerous synthetic cannabinoids.
The drug tianeptine was first developed in France and spread to many countries, gaining popularity under names like Stablon, Coaxil, and Tatinol. Its unique mechanism of action puzzled researchers for years, as it didn’t interact with neurotransmitter receptors like other antidepressants. Eventually, it was discovered that tianeptine targets the mu opioid receptor, working similarly to opioids like morphine.
The drug’s potential therapeutic benefits and neurorestorative properties have intrigued researchers, but its addictive nature has led to abuse and addiction issues. Calls to poison centers regarding tianeptine exposure have been on the rise, with many cases involving young adults. Withdrawal symptoms and reports of habit-forming properties highlight the dangers of tianeptine misuse.
Tragic deaths have been linked to tianeptine, with the drug being implicated in fatal overdoses. States have taken action to ban tianeptine sales, classifying it as a controlled substance. While federal legislation aims to classify tianeptine as a Schedule III drug, the drug’s availability online and in stores continues to fuel the nation’s struggle with opioids.
Efforts to crack down on tianeptine sales have resulted in legal actions and forfeitures of millions of dollars. While there are ongoing challenges in regulating tianeptine, authorities are working to prevent its importation and distribution. The drug’s presence in the opioid crisis underscores the need for comprehensive measures to address its dangers and protect public health.
